Report me for selling fake medicine? Why are you crying when your illness relapses?

This result was indeed horrifying, and it finally made him understand why he hadn't been able to simulate it before.

It turned out that it was not his speculation, nor was there a problem with humans or the medical simulator, but that the test time was not enough.

"Bala, bala, bala..."

"Bala, bala, bala..."

At this moment, the machine suddenly sounded a rapid alarm.

This made Chen Xuan hurried over, because the alarm sound represented a simulated error.

The reason why an error is reported is that an abnormality is found, so a reminder is given in the form of an error.

When he saw the test results of the machine, he couldn't help but feel surprised, and then he was delighted.

Because this error data proved his previous speculation, he did not make any analysis errors, and everything was verified.

There are indeed problems with the Elsilan anti-cancer drug, and they are very serious.

The reason why the clinical trial data was modified is probably because Elshelan's team discovered this problem during the clinical trial.

This problem is likely to lead to the failure of the entire project, turning the priceless anti-cancer drug into a worthless waste drug, which is why it is covered up.

This hidden danger is most likely to be discovered during the Phase III clinical trial, and may only be known to the founder and a few core personnel, so it can be covered up.

If the disease is discovered early in phase I or II clinical trials, it would be impossible to proceed to phase III clinical trials.

They are absolutely unwilling to let all their previous efforts go to waste if things get to this point, especially when faced with a sky-high acquisition price, which makes this team choose to take risks.

When Chen Xuan thought of this, everything became clear.

Judging from the simulation results of humans and medical simulators, the Elsilan anti-cancer drug does have therapeutic effects.

The treatment effect in the first week and the first month was very good. It could temporarily control the breast cancer condition and prevent it from worsening, and even make the patients feel much more relieved.

This can be seen from the simulation results, which are no different from the clinical trials provided by Elshelan.

But after the third month of this simulation,

Chen Xuan discovered something wrong, but it was so subtle that it was usually not noticeable.

This abnormality will not gradually become apparent until half a year after taking the medicine, but it is difficult to discover this problem without a comprehensive examination.

After a year, this situation will gradually lead to serious consequences, such as sudden death from various diseases.

After three years of taking the drug, the mortality rate can be as high as 50%, which is much higher than the mortality rate of breast cancer itself.

In other words, if you do not take this medicine, you are less likely to die. However, long-term use of this medicine for more than three years can lead to a mortality rate of up to 50%.

The reason why the human and medical simulators sounded the alarm is that after three years of simulated medication, a large number of test templates died, with a mortality rate as high as 50%.

Of course, the current mortality rate of Elsilan anti-cancer drugs is not so shocking.

But it’s not because humans and medical simulators make mistakes in their simulations, nor is it because the real situation is better.

This is because so far, no one has taken the anti-cancer drug Elshelan normally for more than three years, and the longest time is just over a year.

The Phase III clinical trial of the Alsiran anti-cancer drug has only been going on for a few months.

However, the first two phases of clinical trials were relatively conservative, and the dosage of drugs used was relatively small. Even if there were problems, it would take a longer time for them to break out.

……

……

Therefore, the 50% mortality rate has not been reflected so quickly, and the current number of deaths is still very small.